SC
Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ·Healthcare·Biotechnology
$0.58
-3.97%
Mkt Cap $974.42K
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Dec 2, 2025 | — | $277.29K | — | — | -$1.33 | — | — | — |
| Q3 2025 Sep 2, 2025 | — | $115.47K | — | — | -$3.57 | — | — | — |
| Q2 2025 May 30, 2025 | — | $158.00K | — | — | -$0.00 | — | — | — |
| Q2 2025 May 7, 2025 | — | $56.54K | — | — | -$10.40 | — | — | — |
| Q4 2024 Nov 22, 2024 | — | $44.21K | — | — | $8.40 | — | — | — |
| Q3 2024 Aug 15, 2024 | — | $75.41K | — | — | -$3.57 | — | — | — |
| Q3 2024 Jul 2, 2024 | — | — | — | — | -$4.00 | — | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.62 | -$240.00 | -38609.68% | — | — |
| Q4 2023 Oct 31, 2023 | — | — | — | -$0.99 | -$6.60 | -566.67% | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$0.91 | -$1.11 | -21.98% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$22.00 | -$1.20 | +94.55% | — | — |
| Q2 2023 Apr 17, 2023 | — | — | — | — | -$0.30 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | -$1.00 | $0.00 | +100.04% | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | -$1.00 | -$0.00 | +99.89% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.00 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | $0.00 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.00 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.00 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.00 | — | — | — |